Atovaquone Suspension
Product Images NDC 42239-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 42239-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abon Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\admin\desktop\new Folder (3)\image2.jpg (Df67ec25 Figure 01)

Chemical structure diagram depicting the molecular composition of Atovaquone, highlighting its key chemical bonds and atomic arrangement.*

FDA Label Image

C:\users\admin\desktop\new Folder (3)\atovaquone Label.jpg (Df67ec25 Figure 02)

Label for Atovaquone Oral Suspension USP, 750 mg/5 mL, manufactured for Abon Pharmaceuticals, LLC. The label indicates a 210 mL bottle size with storage instructions to keep between 15°C to 25°C and not to freeze. It advises shaking gently before use and cautions against using the product if the shrink band on the bottle is broken or missing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.